GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.
about
Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese populationPharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and RadiationOxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsGlutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study.Translational medicine and reliability of single-nucleotide polymorphism studies: can we believe in SNP reports or not?Glutathione S-transferase P1 correlated with oxidative stress in hepatocellular carcinomaPharmacogenomics and metastatic colorectal cancer: current knowledge and perspectives.Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis.Genetic Polymorphisms of Cytochrome P4501A1 (CYP1A1) and Glutathione S-Transferase P1 (GSTP1) and Risk of Hepatocellular Carcinoma Among Chronic Hepatitis C Patients in Egypt.Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients.Response of glutathione S-transferase Pi (GSTP1) to neoadjuvant therapy in rectal adenocarcinoma.Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer
P2860
Q28083875-E03B272A-DE18-45F5-B24E-5F7449DD62FFQ30300958-42FB3E44-BB79-4604-8D15-06688D9570B5Q33747440-7B6D57C3-790A-473A-8CF0-40607E867090Q34008793-64B43968-74CB-4C63-BDA8-B70437BE1A48Q34284168-A7BEA079-4347-4F67-AE98-4672F2CB46A2Q35196724-AB8C8EEF-B30A-4EDB-B023-37BD6B1C5616Q36746926-03DFD548-C5E7-4D69-9EB0-9255941286A6Q37969851-1F8F1149-E0F1-48B8-8611-176148C10FB1Q38827826-E1B585A9-9A0D-4A81-BCBB-3D1EEC9C18A1Q38857260-DAA77725-EA01-46FF-ADF7-D89C2476200DQ39566084-02017AA1-080E-4189-AE34-96AF63424FC4Q39644875-F31B27BC-C1A4-4926-8E24-3486578A5956Q56777795-857E7C6F-DAB9-4C99-87F6-E311CDCD2644
P2860
GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
GSTP1 Ile105Val polymorphism c ...... Dutch Colorectal Cancer Group.
@en
type
label
GSTP1 Ile105Val polymorphism c ...... Dutch Colorectal Cancer Group.
@en
prefLabel
GSTP1 Ile105Val polymorphism c ...... Dutch Colorectal Cancer Group.
@en
P2093
P2860
P356
P1476
GSTP1 Ile105Val polymorphism c ...... Dutch Colorectal Cancer Group
@en
P2093
C J A Punt
D M Kweekel
H Gelderblom
J W R Nortier
N F Antonini
T Van der Straaten
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604654
P407
P577
2008-09-16T00:00:00Z